Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Gains from Investment Securities (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Gains from Investment Securities for 3 consecutive years, with $111817.0 as the latest value for Q2 2022.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $111817.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $111817.0, a N/A change, with the full-year FY2024 number at $11183.0, changed 0.0% from a year prior.
  • Gains from Investment Securities was $111817.0 for Q2 2022 at Creative Medical Technology Holdings, up from $1667.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $111817.0 in Q2 2022 to a low of $111817.0 in Q2 2022.